Your account is not claimed yet. You can sign up with ORCID to claim your account.

Amar H Kelkar (Amar Kelkar)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 9

Top Venues

Healthcare (Basel, Switzerland)

JCO oncology practice

The New England journal of medicine

JCO global oncology

University of Florida Health

Saint George's University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Florida Health Jul 1o 2018

United States

Fellow :: Hematology & Oncology

Education History

Saint George's University

Grenada

PHD :: College of Medicine

Publications

Amar H Kelkar, Edward Robert Scheffer Cliff, Caron A Jacobson, Gregory A Abel, Stijntje Willemijn Dijk, Eline M Krijkamp, Robert A Redd, Joanna C Zurko, Mehdi Hamadani, M G Myriam Hunink, Corey S Cutler
Second-Line Chimeric Antigen Receptor T-Cell Therapy in Diffuse Large B-Cell Lymphoma : A Cost-Effectiveness Analysis. Annals of internal medicine (2023)
Amar H Kelkar, Andrew Hantel, Erica Koranteng, Corey S Cutler, Marilyn J Hammer, Gregory A Abel
Digital Health to Patient-Facing Artificial Intelligence: Ethical Implications and Threats to Dignity for Patients With Cancer. JCO oncology practice (2023)
Edward Robert Scheffer Cliff, Amar H Kelkar, David A Russler-Germain, Frazer A Tessema, Adam J N Raymakers, William B Feldman, Aaron S Kesselheim
High Cost of Chimeric Antigen Receptor T-Cells: Challenges and Solutions. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting 43 (2023)
Matthew D Bloom, Haneen Saker, Chad Glisch, Brian Hemendra Ramnaraign, Thomas J George, Merry-Jennifer Markham, Amar H Kelkar
Administration of Immune Checkpoint Inhibitors Near the End of Life. JCO oncology practice 18 (6) (2022)
Amar H Kelkar, Jing Zhao, Shu Wang, Christopher R Cogle
Impact of the COVID-19 Pandemic on Colorectal and Prostate Cancer Screening in a Large U.S. Health System. Healthcare (Basel, Switzerland) 10 (2) (2022)
Raleigh Ayoolu Fatoki, Kelly Koehn, Amar H Kelkar, Samer A Al Hadidi, Nikita Mehra, Hira S Mian, Carl Ola Landgren, Dickran Kazandjian, James Hoffman, Douglas W Sborov, Ghulam Rehman Mohyuddin
Global Myeloma Trial Participation and Drug Access in the Era of Novel Therapies. JCO global oncology 8 (2022)
Amar H Kelkar, Jodian A Blake, Kartikeya Cherabuddi, Hailee Cornett, Bobbie L McKee, Christopher R Cogle
Vaccine Enthusiasm and Hesitancy in Cancer Patients and the Impact of a Webinar. Healthcare (Basel, Switzerland) 9 (3) (2021)
Amar H Kelkar, Christopher R Cogle
Cancer in the Time of Coronavirus: A Call for Crisis Oncology Standards of Care. Healthcare (Basel, Switzerland) 8 (3) (2020)
Amar H Kelkar, Nichole A Smith, Annia Martial, Harsha Moole, Michael D Tarantino, Jonathan C Roberts
An Outbreak of Synthetic Cannabinoid-Associated Coagulopathy in Illinois. The New England journal of medicine 379 (13) (2018)

Amar H Kelkar.css-eqlu8i{font-size:small;padding-left:4px;} (Amar Kelkar)

Publication Activity (10 Years)

Top Topics

Top Venues

Amar H Kelkar (Amar Kelkar)